Antonella Bruzzese
-
- Acute Myeloid Leukemia Research 11
- Multiple Myeloma Research and Treatments 8
- Chronic Myeloid Leukemia Treatments 3
- Emergency Medical Services top 10%
-
- Chronic Lymphocytic Leukemia Research 7
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
-
- CAR-T cell therapy research 7
-
- Lymphoma Diagnosis and Treatment 4
-
- Protein Degradation and Inhibitors 3
Antonella Bruzzese
28 papers receiving 149 citations
Peers
Comparison fields: 5 of 43
- Hematology 62
- Emergency Medical Services 32
- Internal Medicine 13
- Genetics 25
- Nephrology 12
Countries citing papers authored by Antonella Bruzzese
This map shows the geographic impact of Antonella Bruzzese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonella Bruzzese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonella Bruzzese more than expected).
Fields of papers citing papers by Antonella Bruzzese
This network shows the impact of papers produced by Antonella Bruzzese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonella Bruzzese. The network helps show where Antonella Bruzzese may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Antonella Bruzzese, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 3 | |
| 6 | 2025 | 2 | |
| 7 | 2025 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 5 | |
| 10 | 2024 | 0 | |
| 11 | 2024 | 1 | |
| 12 | 2023 | 1 | |
| 13 | 2023 | 2 | |
| 14 | 2023 | 0 | |
| 15 | 2023 | 11 | |
| 16 | 2023 | 45 | |
| 17 | 2021 | 1 | |
| 18 | 2020 | 16 | |
| 19 | 2020 | 24 | |
| 20 | 2019 | 2 |
About Antonella Bruzzese
Antonella Bruzzese is a scholar working on Hematology, Genetics, Internal Medicine, Nephrology and Emergency Medical Services, having authored 34 papers that have together received 158 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Multiple Myeloma Research and Treatments (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), CAR-T cell therapy research (7 papers), Lymphoma Diagnosis and Treatment (4 papers), Protein Degradation and Inhibitors (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (62 citations), Emergency Medical Services (32 citations), Internal Medicine (13 citations), Genetics (25 citations) and Nephrology (12 citations). Antonella Bruzzese has collaborated with scholars based in Italy and Japan. Frequent co-authors include Ernesto Vigna, Francesco Mendicino, Fortunato Morabito, Eugenio Lucia, Enrica Antonia Martino, Massimo Gentile, Antonino Neri, Gianfranco Filippelli, Isabella Capodanno and Antonio Chistolini. Their work appears in journals such as European Journal Of Haematology, Expert Opinion on Pharmacotherapy, Hematological Oncology, Blood Coagulation & Fibrinolysis and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.